These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35880246)

  • 1. Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma.
    Sun X; Cai M; Wu L; Zhen X; Chen Y; Peng J; Han S; Zhang P
    Cancer Sci; 2022 Oct; 113(10):3463-3475. PubMed ID: 35880246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.
    Xue Y; Guo Y; Liu N; Meng X
    Bioengineered; 2022 Apr; 13(4):9135-9147. PubMed ID: 34753394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of β-catenin.
    Ma P; Yang X; Kong Q; Li C; Yang S; Li Y; Mao B
    Mol Cell Biol; 2014 Dec; 34(23):4355-66. PubMed ID: 25266658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
    Wu WJ; Shi J; Hu G; Yu X; Lu H; Yang ML; Liu B; Wu ZX
    Tumour Biol; 2016 May; 37(5):6045-51. PubMed ID: 26602384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
    Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
    Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer.
    Shen J; Xie M; Xu Y; Qian Q; Qiu T; Shi W; Ren D; Ji J; Huang J
    Biochem Biophys Res Commun; 2023 Jan; 638():184-191. PubMed ID: 36462492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP39 stabilizes β-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression.
    Wang W; Lei Y; Zhang G; Li X; Yuan J; Li T; Zhong W; Zhang Y; Tan X; Song G
    Cell Death Dis; 2023 Jan; 14(1):63. PubMed ID: 36707504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIB2 inhibits Wnt/β-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β-TrCP, COP1 and Smurf1, in liver cancer cells.
    Xu S; Tong M; Huang J; Zhang Y; Qiao Y; Weng W; Liu W; Wang J; Sun F
    FEBS Lett; 2014 Nov; 588(23):4334-41. PubMed ID: 25311538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt3a/β-catenin/TCF7L2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
    Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
    Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer.
    Yun SI; Kim HH; Yoon JH; Park WS; Hahn MJ; Kim HC; Chung CH; Kim KK
    Mol Oncol; 2015 Nov; 9(9):1834-51. PubMed ID: 26189775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis.
    Ip W; Shao W; Chiang YT; Jin T
    Am J Physiol Endocrinol Metab; 2012 Nov; 303(9):E1166-76. PubMed ID: 22967502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.
    Hou N; Ye B; Li X; Margulies KB; Xu H; Wang X; Li F
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-specific protease USP34 regulates axin stability and Wnt/β-catenin signaling.
    Lui TT; Lacroix C; Ahmed SM; Goldenberg SJ; Leach CA; Daulat AM; Angers S
    Mol Cell Biol; 2011 May; 31(10):2053-65. PubMed ID: 21383061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin C-terminal hydrolase37 regulates Tcf7 DNA binding for the activation of Wnt signalling.
    Han W; Lee H; Han JK
    Sci Rep; 2017 Feb; 7():42590. PubMed ID: 28198400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wnt effector transcription factor 7-like 2 positively regulates oligodendrocyte differentiation in a manner independent of Wnt/β-catenin signaling.
    Hammond E; Lang J; Maeda Y; Pleasure D; Angus-Hill M; Xu J; Horiuchi M; Deng W; Guo F
    J Neurosci; 2015 Mar; 35(12):5007-22. PubMed ID: 25810530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
    Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
    World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex.
    Zhu C; Yamaguchi K; Ohsugi T; Terakado Y; Noguchi R; Ikenoue T; Furukawa Y
    Cancer Sci; 2017 Apr; 108(4):612-619. PubMed ID: 28117551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.